Lifeline Biotechnologies Inc.
LLBO
Get informed when a big investor buys or sells
+ FollowMarket Cap$2.17M
Close$
$-0.00
120% downside
Current Fair Value
120% downsideOvervalued by 120% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $2.17 Million |
|---|---|
| Enterprise Value | - |
| Dividend Yield | $- (-) |
| Earnings per Share | $0 |
| Beta | 328.89 |
| Outstanding Shares | 4,348,921,000 |
Return
| Return on Equity | NaN% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | -37.3 |
|---|---|
| PEG | - |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | - |
| Debt to Equity | - |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data